Over 113,000 given first jab of Pfizer-BioNTech in Singapore, only three reported for anaphylaxis
Thursday, 28 Jan 2021 11:51 PM MYT
SINGAPORE, Jan 28 — More than 113,000 individuals in Singapore have received their first dose of the Pfizer-BioNTech Covid-19 vaccine while over 50 individuals have received their second dose and completed the full vaccination regimen, as of Jan 27. “Anaphylaxis is a known but rare side effect of the Pfizer-BioNTech Covid-19 vaccine,” said Director of Medical Services at the republic’s Ministry of Health, Associate Professor Kenneth Mak, in a statement here today.
“We have put in place precautionary measures such as pre-vaccination screening and post-vaccination observation, to ensure that our vaccination programme can be carried out safely.According to the statement, the individuals, in their 20s and 30s, developed multiple symptoms such as rash, breathlessness, lip swelling, throat tightness and giddiness.